DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BLEOMYCIN SULFATE

« Back to Dashboard

Clinical Trials for Bleomycin Sulfate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00025259	Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease	Completed	National Cancer Institute (NCI)	Phase 3	This randomized phase III trial is studying different chemotherapy regimens given with or without radiation therapy to compare how well they work in treating children with newly diagnosed Hodgkin's disease. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known if chemotherapy is more effective with or without additional chemotherapy and/or radiation therapy in treating Hodgkin's disease.
NCT00025259	Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease	Completed	Children's Oncology Group	Phase 3	This randomized phase III trial is studying different chemotherapy regimens given with or without radiation therapy to compare how well they work in treating children with newly diagnosed Hodgkin's disease. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known if chemotherapy is more effective with or without additional chemotherapy and/or radiation therapy in treating Hodgkin's disease.
NCT00038558	Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy	Completed	M.D. Anderson Cancer Center	Phase 3	Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.

Clinical Trial Conditions for Bleomycin Sulfate

Condition Name

Condition Name for Bleomycin Sulfate
Intervention	Trials
Lymphoma	8
Stage IV Childhood Hodgkin Lymphoma	2
Classical Hodgkin Lymphoma	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Bleomycin Sulfate
Intervention	Trials
Hodgkin Disease	15
Lymphoma	12
Neoplasms	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Bleomycin Sulfate

Trials by Country

Trials by Country for Bleomycin Sulfate
Location	Trials
United States	266
Canada	25
Australia	8
Puerto Rico	3
New Zealand	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Bleomycin Sulfate
Location	Trials
California	11
Texas	10
Pennsylvania	8
Illinois	8
Ohio	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Bleomycin Sulfate

Clinical Trial Phase

Clinical Trial Phase for Bleomycin Sulfate
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	7
Phase 2	12

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Bleomycin Sulfate
Clinical Trial Phase	Trials
Recruiting	5
Completed	5
Active, not recruiting	4

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Bleomycin Sulfate

Sponsor Name

Sponsor Name for Bleomycin Sulfate
Sponsor	Trials
National Cancer Institute (NCI)	12
M.D. Anderson Cancer Center	4
Children's Oncology Group	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Bleomycin Sulfate
Sponsor	Trials
Other	22
NIH	12
Industry	4

Export unavailable in trial.
Subscribe for complete access.